Breaking News

New obesity tool goes beyond BMI

April 30, 2026
Brendan SMIALOWSKI/AFP via Getty Images

Trump drops Casey Means as surgeon general nominee, opts for radiologist Nicole Saphier

With Means confirmation stalled, Trump nominates a replacement: Dr. Nicole Saphier, a Memorial Sloan Kettering Cancer Center radiologist.

By Elizabeth Cooney, Chelsea Cirruzzo, and Daniel Payne


STAT+ | DOJ, Elevance spar over access to top exec in Medicare Advantage fraud case

DOJ wants to depose Peter Haytaian, Medicare Advantage chief during alleged fraud. Two days after the request, Elevance said he was leaving the company.

By Bob Herman


STAT+ | Cigna will exit ACA individual markets next year, adding to tumult for patients

Cigna is exiting the ACA individual marketplaces in 2027 to focus on core growth platforms, leaving 369,000 members in 11 states to find new coverage.

By Tara Bannow



Kayte Spector-Bagdady, a bioethicist at the University of Michigan Medical School, is scrambling to find new funding for her staff.
Sylvia Jarrus for STAT

Securing NIH awards is getting more competitive — and confusing

NIH payline crash: Why the drop in grant success rates, disappearing NOFOs, and political shifts are crippling academic research careers.

By Anil Oza


STAT+ | As artificial intelligence shows off diagnostic chops, scientists reckon with the way forward

Study published in Science finds a large language model from OpenAI can outperform physicians in case-based diagnostic and clinical reasoning evaluations.

By Katie Palmer


STAT+ | New obesity tool aims to predict risk of 18 serious complications

A new tool called OBSCORE promises to better define who's at risk for obesity complications, going beyond BMI to include family history, diet, and more.

By Elizabeth Cooney


Adobe

STAT+ | FDA wants to exclude weight loss drugs from a compounding list

FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B list, saying there's no shortage of GLP-1 drugs from Novo Nordisk and Eli Lilly.

By Ed Silverman


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.

No comments